Vetbiobank is a brand that specializes in developing cellular medicines using neonatal stem cells. These innovative therapies have a unique potential to combat chronic inflammatory diseases in dogs, cats, horses, and other animals, whether they are sick, injured, or simply aging. Vetbiobank's products are designed to restore the quality of life and well-being of animals.

The brand is committed to providing the best of regenerative medicine to a wide range of animals. Their biotherapies are developed and manufactured in France, adhering to good practices. Vetbiobank's expertise lies in cellular therapy, and their technologies are developed with a strong focus on ethics and animal welfare.

By harnessing the intact biological potential of neonatal stem cells, Vetbiobank aims to address the underlying causes of various chronic inflammatory diseases that affect animals. Through their therapies, they aim to reduce pain, improve quality of life, and alleviate the burden of treatment for both animals and their owners. Vetbiobank is dedicated to supporting veterinarians with their prescribed and administered products, providing additional expertise, and offering accessible solutions to enhance the lives of animals